Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
Core pathway mutations induce de-differentiation of murine astrocytes into glioblastoma stem cells that are sensitive to radiation but resistant to temozolomide. [electronic resource] by
- Schmid, Ralf S
- Simon, Jeremy M
- Vitucci, Mark
- McNeill, Robert S
- Bash, Ryan E
- Werneke, Andrea M
- Huey, Lauren
- White, Kristen K
- Ewend, Matthew G
- Wu, Jing
- Miller, C Ryan
Producer: 20171012
In:
Neuro-oncology vol. 18
Availability: No items available.
|
|
5.
|
Cooperativity between MAPK and PI3K signaling activation is required for glioblastoma pathogenesis. [electronic resource] by
- Vitucci, Mark
- Karpinich, Natalie O
- Bash, Ryan E
- Werneke, Andrea M
- Schmid, Ralf S
- White, Kristen K
- McNeill, Robert S
- Huff, Byron
- Wang, Sophie
- Van Dyke, Terry
- Miller, C Ryan
Producer: 20140502
In:
Neuro-oncology vol. 15
Availability: No items available.
|
|
6.
|
Genomic profiles of low-grade murine gliomas evolve during progression to glioblastoma. [electronic resource] by
- Vitucci, Mark
- Irvin, David M
- McNeill, Robert S
- Schmid, Ralf S
- Simon, Jeremy M
- Dhruv, Harshil D
- Siegel, Marni B
- Werneke, Andrea M
- Bash, Ryan E
- Kim, Seungchan
- Berens, Michael E
- Miller, C Ryan
Producer: 20180705
In:
Neuro-oncology vol. 19
Availability: No items available.
|
|
7.
|
PIK3CA missense mutations promote glioblastoma pathogenesis, but do not enhance targeted PI3K inhibition. [electronic resource] by
- McNeill, Robert S
- Stroobant, Emily E
- Smithberger, Erin
- Canoutas, Demitra A
- Butler, Madison K
- Shelton, Abigail K
- Patel, Shrey D
- Limas, Juanita C
- Skinner, Kasey R
- Bash, Ryan E
- Schmid, Ralf S
- Miller, C Ryan
Producer: 20190101
In:
PloS one vol. 13
Availability: No items available.
|
|
8.
|
MerTK as a therapeutic target in glioblastoma. [electronic resource] by
- Wu, Jing
- Frady, Lauren N
- Bash, Ryan E
- Cohen, Stephanie M
- Schorzman, Allison N
- Su, Yu-Ting
- Irvin, David M
- Zamboni, William C
- Wang, Xiaodong
- Frye, Stephen V
- Ewend, Matthew G
- Sulman, Erik P
- Gilbert, Mark R
- Earp, H Shelton
- Miller, C Ryan
Producer: 20190131
In:
Neuro-oncology vol. 20
Availability: No items available.
|
|
9.
|
Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer. [electronic resource] by
- Van Swearingen, Amanda E D
- Sambade, Maria J
- Siegel, Marni B
- Sud, Shivani
- McNeill, Robert S
- Bevill, Samantha M
- Chen, Xin
- Bash, Ryan E
- Mounsey, Louisa
- Golitz, Brian T
- Santos, Charlene
- Deal, Allison
- Parker, Joel S
- Rashid, Naim
- Miller, C Ryan
- Johnson, Gary L
- Anders, Carey K
Producer: 20180627
In:
Neuro-oncology vol. 19
Availability: No items available.
|
|
10.
|
Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma. [electronic resource] by
- McNeill, Robert S
- Canoutas, Demitra A
- Stuhlmiller, Timothy J
- Dhruv, Harshil D
- Irvin, David M
- Bash, Ryan E
- Angus, Steven P
- Herring, Laura E
- Simon, Jeremy M
- Skinner, Kasey R
- Limas, Juanita C
- Chen, Xin
- Schmid, Ralf S
- Siegel, Marni B
- Van Swearingen, Amanda E D
- Hadler, Michael J
- Sulman, Erik P
- Sarkaria, Jann N
- Anders, Carey K
- Graves, Lee M
- Berens, Michael E
- Johnson, Gary L
- Miller, C Ryan
Producer: 20180627
In:
Neuro-oncology vol. 19
Availability: No items available.
|